Gold prices cool after hitting over 2-week high on Fed independence fears
Oramed Pharmaceuticals Inc (NASDAQ:ORMP). (NASDAQ:ORMP; Tel Aviv:ORMP), a pharmaceutical company with a market capitalization of $84.88 million and strong cash position relative to debt, held its 2025 Annual Meeting of Stockholders on Tuesday. According to a press release statement and SEC filing, stockholders approved an amendment to the company’s Amended and Restated 2019 Stock Incentive Plan, increasing the number of authorized shares for issuance by 2,000,000 to a total of 9,500,000 shares of common stock.
The amendment, previously approved by the board of directors subject to stockholder approval, makes officers and directors among those eligible to receive awards under the plan, in accordance with its terms. InvestingPro subscribers have access to 8 additional key insights about Oramed’s financial position and future prospects.
At the same meeting, stockholders re-elected all current directors to serve until the next annual meeting or until their successors are elected and qualified. The directors re-elected were Dr. Daniel Aghion, Dr. Miriam Kidron, Nadav Kidron, Dr. Arie Mayer, Yehuda Reznick, Leonard Sank, and Benjamin Shapiro. Vote totals for each director ranged from approximately 12.5 million to 13 million shares in favor, with between 163,976 and 1,375,014 shares against, and over 1.1 million abstentions for each nominee. Broker non-votes totaled 6,384,104 shares for each director.
Stockholders also ratified the appointment of Kesselman & Kesselman, certified public accountants in Israel and a member of PricewaterhouseCoopers International Limited, as the company’s independent registered public accounting firm for the 2025 fiscal year. The ratification received 19,408,725 votes in favor, 1,359,336 against, and 17,992 abstentions.
The information in this article is based on a press release statement and the related Form 8-K filed with the Securities and Exchange Commission. Oramed Pharmaceuticals’ common stock is traded on the Nasdaq Capital Market and the Tel Aviv Stock Exchange under the symbol ORMP.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.